Inter Parfums, Inc. (IPAR)

Nasdaq Consumer Staples Household Products S&P SmallCap 600
$135.55
+0.27 (+0.20%)
Close of Nov 06, 2026 · end-of-day data

IPAR 8-K filings in 2026

Every material Form 8-K Inter Parfums filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2026817 on record in all
Latest filing in 2026Nov 04, 2026guidance
High impact (4-5)1of 8 briefs
TonePositive5Mixed3
earnings 7guidance 1
Nov 4, 4:49 PM ET

Interparfums raises 2026 sales guidance to $1.49 billion as Q3 diluted EPS rises to $2.13

Positive guidance 2.027.018.01

Interparfums reported third-quarter 2026 net sales of $430 million, flat from a year earlier, and diluted EPS of $2.13, up from $2.05. The company raised its 2026 sales outlook to $1.49 billion from $1.48 billion and kept its 2026 EPS outlook at $4.85, which matters to shareholders because higher sales guidance and rising profit per share point in the same direction.

  • Q3 2026 net sales were $430 million, flat year over year; diluted EPS was $2.13 versus $2.05.
  • Nine-month 2026 net sales rose 1% to $1.1 billion, and nine-month diluted EPS rose 2% to $4.43.
  • 2026 sales outlook raised from $1.48 billion to $1.49 billion; 2026 EPS outlook maintained at $4.85.
  • Initial 2027 guidance will be released on November 18, 2026; the $0.80 quarterly dividend is payable December 31, 2026.
Read the filing on SEC.gov ↗
Oct 20, 4:25 PM ET

Interparfums Q3 2026 net sales flat at $430 million; nine-month sales up 1% to $1.115 billion

Mixed earnings 2.027.01

Interparfums reported third-quarter 2026 net sales of $430 million, unchanged from the prior year, and nine-month sales of $1.115 billion, up 1%. European based operations grew 4% in the quarter while United States based operations fell 7%, partly due to about $10 million of delayed giftset shipments that will now be recognized in the fourth quarter. The release covers net sales only; full quarterly results are scheduled for November 4, 2026.

  • Q3 2026 net sales: $430 million, flat versus $430 million in Q3 2025
  • Nine-month 2026 net sales: $1.115 billion, up 1% from $1.102 billion
  • European based net sales rose 4% to $306 million in Q3; United States based net sales fell 7% to $127 million
  • Full third-quarter and nine-month results due November 4, 2026 after market close; conference call November 5, 2026 at 11:00 am ET
Read the filing on SEC.gov ↗
Aug 4, 4:30 PM ET

Interparfums Q2 sales rise 2% to $341 million; EPS falls to $0.95, guidance kept

Mixed earnings Written later 2.027.018.01

Interparfums reported second-quarter 2026 net sales of $341 million, up 2% from a year earlier, but diluted EPS fell to $0.95 from $0.99 and operating income dropped 17% to $49 million. The company reaffirmed its 2026 outlook of $1.48 billion in sales and EPS of $4.85, and it spent more on advertising and promotion, so shareholders face higher costs against steady top-line growth.

  • Q2 2026 net sales $341 million (+2%); first-half net sales $686 million (+2%)
  • Q2 diluted EPS $0.95 vs. $0.99 a year ago; operating margin 14.4% vs. 17.7%
  • 2026 guidance reaffirmed: $1.48 billion in sales and EPS of $4.85
  • Quarterly dividend of $0.80 per share payable September 30, 2026
Read the filing on SEC.gov ↗
Jul 22, 4:27 PM ET

Interparfums Q2 2026 net sales rise 2% to $341 million as US sales jump 18%

Positive earnings Written later 2.027.01

Interparfums reported second-quarter 2026 net sales of $341 million, up 2% from $334 million a year earlier, and first-half net sales of $686 million, also up 2%. The gain came from U.S.-based operations, which rose 18%, while European-based sales fell 4%. The release gives sales only; the company said it will report full earnings for the period on August 4, 2026.

  • Q2 2026 net sales were $341 million versus $334 million in Q2 2025, up 2%.
  • First-half 2026 net sales were $686 million versus $673 million, up 2%.
  • U.S.-based net sales rose 18% to $113 million; European-based net sales fell 4% to $231 million.
  • The company will report earnings for the three and six months ended June 30, 2026 on August 4, 2026, with a conference call on August 5, 2026.
Read the filing on SEC.gov ↗
May 5, 4:43 PM ET

Interparfums Q1 2026 net sales rise 2% to $345 million; EPS $1.35; guidance reaffirmed

Positive earnings Written later 2.027.018.01

Interparfums reported first-quarter 2026 net sales of $345 million, up 2% from $339 million, and diluted EPS of $1.35 versus $1.32 a year earlier. The company reaffirmed its full-year 2026 outlook of $1.48 billion in sales and EPS of $4.85, and declared a $0.80 quarterly dividend payable June 30, 2026.

  • Q1 2026 net sales $345 million (up 2%); net income attributable to Interparfums $43 million vs. $42 million
  • Gross margin 65.1% vs. 63.7%; operating income $74 million vs. $75 million, operating margin 21.5% vs. 22.2%
  • 2026 guidance reaffirmed: $1.48 billion in sales and EPS of $4.85
  • Quarterly dividend of $0.80 per share payable June 30, 2026, to holders of record June 15, 2026
Read the filing on SEC.gov ↗
Apr 21, 4:21 PM ET

Interparfums Q1 2026 net sales rise 2% to $345 million; Middle East forecast cut

Mixed earnings Written later 2.027.01

Interparfums reported first-quarter 2026 net sales of $345 million, up 2% from $339 million, with a positive 4.6% foreign exchange impact. CEO Jean Madar said organic sales declined 2% excluding the Middle East war, and the company reduced its forecast for the Middle East region. Full first-quarter financial results are not included in this filing and will be issued May 5, 2026.

  • Q1 2026 net sales $345 million vs $339 million in Q1 2025, up 2% on a reported basis
  • CEO said organic sales declined 2%; the war in the Middle East was an estimated 1% headwind
  • Company reduced its forecast for the Middle East region but said it remains cautiously optimistic for 2026
  • Full results for the quarter ended March 31, 2026 due May 5, 2026, with a conference call on May 6, 2026 at 11:00 am ET
Read the filing on SEC.gov ↗
Feb 24, 5:22 PM ET

Interparfums reports record 2025 sales of $1.49 billion and reaffirms 2026 guidance

Positive earnings Written later 2.027.018.01

Interparfums reported record fourth-quarter and full-year 2025 results, with full-year net sales of $1.49 billion (up 2%) and diluted EPS of $5.24 (up from $5.12). The company reaffirmed its 2026 outlook of $1.48 billion in sales and $4.85 in EPS and kept its annual dividend at $3.20 per share, but said it may revisit guidance later in 2026.

  • Fourth-quarter 2025 net sales rose 7% to $386 million and diluted EPS rose 16% to $0.88, while operating income fell 24% to $28 million.
  • Full-year 2025 operating income was $270 million, down 2% from $275 million, with operating margin of 18.2% versus 18.9%.
  • 2026 guidance is $1.48 billion in sales and $4.85 EPS, unchanged; the company will monitor early-2026 developments before potentially revisiting it.
  • The Board approved a 2026 annual cash dividend of $3.20 per share, unchanged from 2025; the next $0.80 quarterly dividend is payable March 31, 2026.
Read the filing on SEC.gov ↗
Jan 21, 4:21 PM ET

Interparfums reports record 2025 net sales; Q4 sales rise 7% to $386 million

Positive earnings Written later 2.027.01

Interparfums reported fourth-quarter 2025 net sales of $386 million, up 7% from $362 million a year earlier, and full-year net sales of $1.49 billion, up 2%. The release covers net sales only; full financial results, including profit, will be issued on February 24, 2026, so shareholders will not see earnings until then.

  • Q4 2025 net sales were $386 million, up 7% on a reported basis and 3% on an organic basis.
  • U.S.-based net sales fell 6% for the full year to $482 million, while European-based net sales rose 7% to $1.02 billion.
  • Full results will be released February 24, 2026, with a conference call on February 25, 2026 at 11:00 am ET.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Inter Parfums filing is on SEC EDGAR ↗. 8-K briefs of other companies →